Possible mechanisms or signaling pathways involved in the anti-GBM activity of these antipsychotic drugs include voltage-gated ion channels and transporters, src oncogenic tyrosine kinase signaling, epigenetic modification of histone deacetylase, wnt/β-catenin signaling, and autophagy [18]. This evidence concerns the gene SRC and glioblastoma.